NCT00131261 - Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

June 30, 2007

Conditions

Multiple Myeloma

Interventions

DRUG

PXD101

DRUG

Dexamethasone

Trial Locations (10)

Rigshospitalet, Copenhagen

Research Facility, New York

H. Lee Moffitt Cancer Center, Tampa

Northwestern University, Chicago

James Berenson, MD, Inc, West Hollywood

Research Facility, Bergen

Research Facility, Oslo

Research Facility, Trondheim

Christie Hospital NHS Trust, Manchester

The Royal Marsden NHS Trust, Surrey